For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of Tafamidis and Attruby represents a significant advancement . These innovative therapies protect the transthyretin protein, preventing its destructive build-up and reducing the burden of the illness. People are now seeing positive o… Read More